Prosecution Insights
Last updated: April 19, 2026

VENN BIOSCIENCES CORPORATION

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18421663 DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES SCHULTZHAUS, JANNA NICOLE 1685 Final Rejection Jan 24, 2024
18180789 IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND TREATMENT MONITORING XU, XIAOYUN 1797 Final Rejection Mar 08, 2023
17759714 BIOMARKERS FOR DIAGNOSING OVARIAN CANCER SABOUR, GHAZAL 1686 Non-Final OA Jul 28, 2022
17433971 BIOMARKERS FOR DIAGNOSING OVARIAN CANCER JONES-FOSTER, ERICA NICOLE 1656 Final Rejection Aug 25, 2021

Managing VENN BIOSCIENCES CORPORATION's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month